India's No.1 Weekly For The Pharmaceutical Industry
About us || Feedback|| Advertising || Subscribe || Archives 

Issue dated - 20th June 2002

Home > Scrips > Full Story Printer Friendly Page|  Email this page

Pharma scrips gain due to selective buying by FIIs

The Bombay Stock Exchange on the first trading of the week (Monday 10) opened at 3136 and closed at 3126. On the last trading day fresh fears of Indo Pak war loomed large over the sensex. It closed at 3218 registering a gain of 92 points.

Some of the major gainers were: Abbott Labs 157.05 (153); Ajanta 52.5 (49.75); Alembic 134.95 (124.15); Aurobindo 244.80 (230.20); Aventis 405.45 (414.70) Burroughs Wellcome 217.65 (210); Cadila 133.90 (131.95); Dr Reddy’s 999.20 (970.30); Elder 37 (36.55); German Remedies 298.65 (295.50); J B Chemicals 204.80 (186.60); Morepen 57.90 (55.90); Nicholas Piramal 266.10 (263.25); Panacea Biotech 350.10 (342); Parke Davis 184.90 (179.95); Pfizer 475.75 (470.65); Ranbaxy 849.60 (827.75); Sun Pharma 566.75 (548.85); Torrent Pharma 209.50 (200); Zandu 1800 (1740)

The major losers were: Cipla 993.20 (999.60); Dabur 51.90 (52.65); IPCA Labs 127.25 (130.05); Knoll Pharma 299.55 (302); Suven Pharma 78 (78.50); Wockhardt 493.50 (495.50)

Inside Pharma

Pharma Pulse
Corporate Monitor
Happennings
Editorial
Scrips
Policies & Amend.
Bulk Drug Trends
Market Place
Product
Biotech
Conversation

Archives
Subscribe
Customer Service
Contact Us
Advertise
About Us

 Network Sites

  Express Computer

  IT People
  Network Magazine
  Business Traveller
  Hotelier & Caterer
  Travel & Tourism
  Exp. Backwaters
  Healthcare Mgmt.
  Express Textile
 Group Sites
  ExpressIndia
  Indian Express
  Financial Express
<Top of page>
ABOUT US FEEDBACK ADVERTISE SUBSCRIBE ARCHIVES
 


© Copyright 2000: Indian Express Group (Mumbai, India). All rights reserved throughout the world. This entire site is compiled in Mumbai by
The Business Publications Division of the Indian Express Group of Newspapers. Please contact our Webmaster for any queries on this site.